Veracyte | VCYT - Операционный доход





Операционный доход Изменить Дата
Agenus USD 15.05M 656K 2026-03
Agilent USD 399M 46M 2026-03
Anika Therapeutics USD 646K 3.88M 2025-12
Arrowhead Research USD -170.09M 28.83M 2026-06
Bruker USD 69.6M 59.4M 2026-06
Heron Therapeutics USD 38K 3.83M 2025-12
Illumina USD 260M 21M 2026-06
Intrexon USD -60.84M 26.62M 2024-06
Karyopharm Therapeutics USD -26.76M 8.92M 2026-03
Laboratory Of America USD 456.7M 46.6M 2026-06
Ligand Pharmaceuticals USD 56.62M 3.7M 2026-06
Myriad Genetics USD -3M 20.3M 2025-12
Rigel Pharmaceuticals USD 14.06M 13.61M 2024-09
Roche Holding CHF 11.46B 1.91B 2026-06
Sangamo BioSciences USD -33.51M 12.77M 2024-06
Siemens EUR 3.19B 508M 2026-06
Sonic Healthcare AUD 435.76M 193.66M 2024-12
Thermo Fisher Scientific USD 2.18B 273M 2026-06
Veracyte USD 23.96M 4.88M 2026-06
Waters USD -86M 234M 2026-06